Compare, Analyse Wockhardt with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs ACTAVIS (US) - Comparison Results

WOCKHARDT     Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT   ACTAVIS
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
ACTAVIS
Dec-18
WOCKHARDT/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,01214,478-   
Low Rs5329,712-   
Sales per share (Unadj.) Rs355.93,551.4-  
Earnings per share (Unadj.) Rs-60.3-1,143.9-  
Cash flow per share (Unadj.) Rs-46.8374.2-  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.814,647.7-  
Shares outstanding (eoy) m110.63332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.23.4 63.7%   
Avg P/E ratio x-12.8-10.6 121.1%  
P/CF ratio (eoy) x-16.532.3 -51.1%  
Price / Book Value ratio x3.00.8 362.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,3794,022,682 2.1%   
No. of employees `0006.316.9 37.0%   
Total wages/salary Rs m9,3710-   
Avg. sales/employee Rs Th6,295.069,892.5 9.0%   
Avg. wages/employee Rs Th1,498.30-   
Avg. net profit/employee Rs Th-1,066.3-22,512.4 4.7%   
INCOME DATA
Net Sales Rs m39,3691,181,183 3.3%  
Other income Rs m1,20222,588 5.3%   
Total revenues Rs m40,5711,203,771 3.4%   
Gross profit Rs m1830,953 0.1%  
Depreciation Rs m1,495504,930 0.3%   
Interest Rs m2,55568,161 3.7%   
Profit before tax Rs m-2,830-519,550 0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-3,582132,506 -2.7%   
Tax Rs m257-6,584 -3.9%   
Profit after tax Rs m-6,669-380,460 1.8%  
Gross profit margin %02.6 1.8%  
Effective tax rate %-9.11.3 -716.7%   
Net profit margin %-16.9-32.2 52.6%  
BALANCE SHEET DATA
Current assets Rs m33,796484,460 7.0%   
Current liabilities Rs m26,917428,569 6.3%   
Net working cap to sales %17.54.7 369.3%  
Current ratio x1.31.1 111.1%  
Inventory Days Days7920 405.1%  
Debtors Days Days8966 134.6%  
Net fixed assets Rs m39,664133,703 29.7%   
Share capital Rs m5530-   
"Free" reserves Rs m27,9680-   
Net worth Rs m28,5224,871,829 0.6%   
Long term debt Rs m21,7311,715,548 1.3%   
Total assets Rs m81,6207,615,778 1.1%  
Interest coverage x-0.1-6.6 1.6%   
Debt to equity ratio x0.80.4 216.4%  
Sales to assets ratio x0.50.2 311.0%   
Return on assets %-5.0-4.1 122.9%  
Return on equity %-23.4-7.8 299.4%  
Return on capital %-7.7-4.8 158.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m8,0190-   
CASH FLOW
From Operations Rs m684421,992 0.2%  
From Investments Rs m6,302231,830 2.7%  
From Financial Activity Rs m-7,695-724,265 1.1%  
Net Cashflow Rs m-664-70,091 0.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare WOCKHARDT With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare WOCKHARDT With: WYETH LTD  DR. REDDYS LAB  PIRAMAL ENTERPRISES  SUVEN LIFESCIENCES  ALEMBIC LTD  



Today's Market

Sensex Opens Higher; Realty Stocks Rally(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.2% while the Hang Seng is up 0.2%.

Related Views On News

WOCKHARDT Announces Quarterly Results (3QFY20); Net Profit Up 125.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, WOCKHARDT has posted a net profit of Rs 192 m (up 125.0% YoY). Sales on the other hand came in at Rs 9 bn (down 16.9% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

WOCKHARDT Announces Quarterly Results (1QFY20); Net Profit Up 57.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, WOCKHARDT has posted a net profit of Rs 369 m (up 57.2% YoY). Sales on the other hand came in at Rs 9 bn (down 14.3% YoY). Read on for a complete analysis of WOCKHARDT's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1 (Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market (Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium (Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying? (Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

WOCKHARDT SHARE PRICE


Jul 9, 2020 10:19 AM

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT

WOCKHARDT - DISHMAN PHARMA COMPARISON

COMPARE WOCKHARDT WITH

FEATURED VIDEOS

MARKET STATS